Frequency of factor V leiden mutation

Journal of the College of Physicians and Surgeons Pakistan

Volumn 15, Issue 1, 2005, Pages 15-17

  Nasiruddin, A ^c   Zahur ur Rehman, A ^a   Anwar, Masood ^b   Ahmed, Suhaib ^c   Ayyub, Muhammad ^b   Ali, Waqar ^b  

^a BAQAI MEDICAL UNIVERSITY   (Pakistan)

^b ARMED FORCES INSTITUTE OF PATHOLOGY   (Pakistan)

^c PNS Shifa ^*  (Pakistan)

Author keywords

Factor V leiden; Mutation; Population genetics; Thrombophilia

Indexed keywords

BLOOD CLOTTING FACTOR 5 LEIDEN; CHLOROFORM; DNA FRAGMENT; EDETIC ACID; PHENOL;

ADULT; AFRICA; ARTICLE; ASIAN; BASE PAIRING; BLOOD SAMPLING; CONTROLLED STUDY; DNA DETERMINATION; DNA EXTRACTION; EUROPE; FEMALE; GEL ELECTROPHORESIS; GENE FREQUENCY; HETEROZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; MUTATIONAL ANALYSIS; PAKISTAN; POLYMERASE CHAIN REACTION; POPULATION GENETICS; PREVALENCE; RACE DIFFERENCE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; THROMBOPHILIA;

ADULT; FACTOR V; FEMALE; GENETIC SCREENING; HUMANS; MALE; PAKISTAN; PILOT PROJECTS; POINT MUTATION; PREVALENCE; THROMBOPHILIA;

EID: 14844300854     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Seligsohn U, Lubetsky A. Genetic susceptibility to venous thrombosis. N Engl J Med 2001; 344:1222-31.
2. Dahlback B, Carlsson M, Svensson PJ. Familial thrombophilia due to a previously unrecognized mechanism characterized by poor anticoagulant response to activated protein C, prediction of a cofactor to activated protein C. Pro NATR Acad Sci USA 1993; 90 1004-8.
3. Svensson PJ, Dahlback B. Resistance to activated protein C as basis for venous thrombosis. N Engl J Med 1994; 330: 517-22.
4. Bertina RM, Koeleman BP, Koster T, Rosendall FR, Dirven RJ, de Ronde H, et al. Mutation in the blood coagulation factor V associated with resistance to activated protein C. Nature 1994; 369: 64-7.
5. Beauchamp NJ, Daley ME, Cooper PC, Preston, FE, Peake IR. Rapid two-stage PCR for detecting factor V G 1691 A mutation. Lancet 1994; 344: 694-5.
6. Lucotte G, Mercier G. Population genetics of factor V leiden in Europe. Blood Cell Mol Dis 2001; 27: 362-7.
7. Sambrook J, Fritsch EF, Maniatus T. Molecular cloning: a laboratory manual. 2nd ed. New York: Cold Spring Harbour Laboratory 1989.
8. De Stefano V, Finazzi G, Mannucci PM. Inherited thrombophilia: pathogenesis, clinical syndromes, and management. Blood 1996; 87: 3531-44.
9. Simkova M, Simko F, Kovacs L. Resistance to activated protein C - frequent etiologic factor for venous thrombosis. Bratisl Lek Listy 2001; 102: 240-7.
10. Kupfermine MJ, Eldor A, Steinman N, Many A, Bar-Am A, Jaffa A, et al. Increased frequency of genetic thrombophilia in women with complications of pregnancy. N Engl J Med 1999; 340: 9-13.
11. Irani-Hakimi N, Tamim H, Kreidy R, Almawi WY. The prevalence of factor V R 506 Q mutation-leiden among apparently healthy Lebanese. Am J Haematol 2000; 65: 45-9.
12. Angelopoulou K, Nicolaides A, Constantinou DC. Prevalence of genetic mutations that predispose to thrombophilia in a Greek Cypriot population. Clin Appl Thromb Haemostat 2000; 6:104-7.
13. Antoniadi T, Htzis T, Kroupis C, Economou-Petersen E, Petersen MB. Prevalence of factor V leiden, prothrombin G20210A and MTHFR C677T mutations in a Greek population of blood donors. Am J Hematol 1999; 61: 265-7.
14. Ioannou HV, Mitsis M, Eleftheriou A, Mastagas M, Nousias V, Rigopoulos C, et al. The presence of factor V leiden as a risk factor for venous thromboembolism in the population of Northwestern Greece. Int Angiol 2000; 19: 314-8.
15. Renner W, Koppel H, Hoffmann C, Schallmoser K, Stanger O, Toplak H, et al. Prothrombin G20210A, factor V leiden and factor XIII Val34Leu: common mutations of blood coagulation factors and deep vein thrombosis in Austria. Thromb Res 2000; 99: 35-9.
16. Gurgey A, Mesci I. The prevalence of factor V leiden (1691 G-) mutation in Turkey. Turkish J Paedtr 1997; 39: 313-5.
17. Livingstone WJ, Keenan C, White B, Mynett-Johnson L, Lawler M, Mayne P, et al. Prevalence of the factor VR506Q mutation in two Irish control populations: use of a novel nested polymerase chain reaction approach. Br J Haematol 2000; 111: 559-61.
18. Hessner MJ, Luhm RA, Pearson SL, Endean DJ, Friedman KD, Montgomery RR. Prevalence of prothrombin G20210A, factor V G1691A (leiden) and methyltetrahydrofolate reductase (MTHFR) C677T in seven different populations determined by multiplex allele-specific PCR. Thromb Haemostat 1999; 81: 733-8.
19. Vizcaino G, Torres E, Quintero J, Hermann F, Grimm R, Diez-Ewald M, et al. Prevalence of activated protein C resistance in indigenous and black populations of the western Venezuela. Invest Clin 2000; 41: 29-36.
20. Garewal G, Das R, Trehan U. Factor V prevalence in the indigenous population and cases of thrombosis in North India. Br J Haematol 1997; 97: 940.
21. Herrmann FH, Koesling M, Schroder W, Altman R, Jimenez Boullar R, Loacink S, et al. Prevalence of factor V leiden mutation in various populations. Genet Epidemiol 1997; 14: 403-11.
22. Angchaisuksiri P, Pingsuthiwong S, Aryuchai K, Busabaratane M, Smer T, Atuhartakarn V, et al. Prevalence of the G1691A mutation in the factor V gene (factor V leiden) and the G20210A prothrombin gene mutation in the Thai population. Am J Haematol 2000; 65 119-22.
23. Ho CH, Chau WK, Hsu HC, Gau JP, Chih CM. Prevalence of factor V leiden in the Chinese population. Zhonghua Yi Xue Za Zhi (Taipei) 1999; 62: 875-8.